Platelet-rich plasma injections.
Danielle Perry, Joey Ton, Michael R Kolber
Author Information
- Danielle Perry: Knowledge Translation Expert with the PEER Group in the Department of Family Medicine at the University of Alberta in Edmonton.
- Joey Ton: Knowledge Translation Expert with the PEER Group in the Department of Family Medicine at the University of Alberta in Edmonton.
- Michael R Kolber: Professor with the PEER Group in the Department of Family Medicine at the University of Alberta in Edmonton.
No abstract text available.
- Clin Rehabil. 2013 Feb;27(2):113-22
[PMID: 23035005]
- Am J Sports Med. 2016 Aug;44(8):1990-7
[PMID: 27257167]
- Clin Orthop Relat Res. 2018 Aug;476(8):1633-1641
[PMID: 29601383]
- Skeletal Radiol. 2013 Nov;42(11):1515-20
[PMID: 23912197]
- Br J Sports Med. 2019 Feb;53(4):251-262
[PMID: 30301735]
- Am J Sports Med. 2013 Nov;41(11):2609-16
[PMID: 23893418]
- Platelets. 2018 May;29(3):213-227
[PMID: 28759287]
- JAMA. 2010 Jan 13;303(2):144-9
[PMID: 20068208]
- Am J Sports Med. 2017 Jul;45(9):2034-2043
[PMID: 28530451]
- Am J Sports Med. 2013 Mar;41(3):625-35
[PMID: 23328738]
Humans
Platelet-Rich Plasma
Treatment Outcome
